BioSerenity

Paris, France Founded: 2014 • Age: 12 yrs
Provider of smart healthcare solutions for sleep and EEG lab management
Request Access

About BioSerenity

BioSerenity is a company based in Paris (France) founded in 2014.. BioSerenity has raised $120.96 million across 4 funding rounds from investors including Dassault Systems, Bpifrance and Idinvest Partners. BioSerenity offers products and services including Neuronaute, ICECap, and EEG Platform. BioSerenity operates in a competitive market with competitors including Ceribell, Empatica, INBRAIN Neuroelectronics, Sleepiz and BrainScope, among others.

  • Headquarter Paris, France
  • Sectors
    Healthcare
    Technology
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Bioserenity Medical Devices Group
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Technology → Artificial Intelligence & Machine Learning
Healthcare → Health Technology & Digital Health
Healthcare → Health Technology & Digital Health
Healthcare → Health Technology & Digital Health
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $120.96 M (USD)

    in 4 rounds

  • Latest Funding Round
    $25.64 M (USD), Private Equity Round

    Nov 13, 2023

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of BioSerenity

BioSerenity offers a comprehensive portfolio of products and services, including Neuronaute, ICECap, and EEG Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Compact device for real-time EEG monitoring and remote diagnostics.

Adaptable caps for EEG devices from neonates to adults.

Platform for uploading and accessing EEG data remotely.

People of BioSerenity
Headcount 200-500
Employee Profiles 28
Employee Profiles
People
Ludivine Rosset
Product Validation R&d Engineer
People
Muriel Baillieul
Developpeur Fullstack
People
Samy El Shewey
Ingenieur Infra R&d
People
Dawn Clayton Rrt
National Director Of Sleep And Scheduling Operations

Unlock access to complete

Funding Insights of BioSerenity

BioSerenity has successfully raised a total of $120.96M across 4 strategic funding rounds. The most recent funding activity was a Private Equity Round round of $25.64 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Private Equity Round — $25.6M
  • First Round

    (04 Jun 2015)

  • Investors Count 6
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2023 Amount Private Equity Round - BioSerenity Valuation Jolt Capital
Jun, 2019 Amount Series B - BioSerenity Valuation Dassault Systems
Sep, 2017 Amount Series A - BioSerenity Valuation LBO France
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in BioSerenity

BioSerenity has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Dassault Systems, Bpifrance and Idinvest Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Private equity firm focused on buyouts of tech-driven companies
Founded Year Domain Location
Private equity investments are made in France and the US.
Founded Year Domain Location
Equity investments are provided to low and middle market companies.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by BioSerenity

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - BioSerenity

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Bioserenity Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of BioSerenity

BioSerenity operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ceribell, Empatica, INBRAIN Neuroelectronics, Sleepiz and BrainScope, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Portable EEG devices for point-of-care seizure diagnosis are provided.
domain founded_year HQ Location
Developer of a wrist band to monitor physiological signals
domain founded_year HQ Location
AI-based neuroelectronic devices for brain disorder detection are developed.
domain founded_year HQ Location
Provider of an AI-based sleep monitoring device for patients and physicians
domain founded_year HQ Location
Developer of AI-driven EEG platform transforming brain electrical activity into insights
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Bioserenity

Frequently Asked Questions about BioSerenity

When was BioSerenity founded?

BioSerenity was founded in 2014 and raised its 1st funding round 1 year after it was founded.

Where is BioSerenity located?

BioSerenity is headquartered in Paris, France.

Is BioSerenity a funded company?

BioSerenity is a funded company, having raised a total of $120.96M across 4 funding rounds to date. The company's 1st funding round was a Series A of $17.97M, raised on Jun 04, 2015.

What does BioSerenity do?

BioSerenity was founded in 2014 in Paris, France, within the healthcare sector. Operations focus on software for managing sleep and EEG laboratories, including scheduling, home sleep testing processing, and remote patient interactions. An EEG device called ICECAP is also offered for inpatient and outpatient use. These tools support healthcare providers in streamlining diagnostic workflows.

Who are the top competitors of BioSerenity?

BioSerenity's top competitors include Ceribell, Empatica and INBRAIN Neuroelectronics.

What products or services does BioSerenity offer?

BioSerenity offers Neuronaute, ICECap, and EEG Platform.

Who are BioSerenity's investors?

BioSerenity has 6 investors. Key investors include Dassault Systems, Bpifrance, Idinvest Partners, Kurma Partners, and Jolt Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available